Amount of Injectable Agents for Carcinoma Therapy Used at 10 National University Dental Hospitals in Japan.
スポンサーリンク
概要
- 論文の詳細を見る
The amount and kinds of injections for carcinoma purchased between Apr. 1, 1995 and Mar. 31 1996, at 10 national university dental hospitals in Japan were investigated.The most commonly used anticancer agents were the platinum complexes. Although three different platinum comlex agents were used, cisplatin was the most commonly used agent. The second commonly used agent was Picibanil<SUP>®</SUP>; four different potency preparations (0.1-5KE) were available on the market. The most frequently used Picibanil<SUP>®</SUP> agent was 1KE, which constituted 81 % of these prescriptions. The antimetabolites agents were the third most commonly purchased anticancer preparations. Tegaful and 5-fluorouracil were the two approved agents of this class used by dental hospitals for cancer of the head and neck. Antibiotics were the fourth most commonly used class of anticancer agents. Peplomycin sulfate was the most frequently used antibiotic (50 %), bleomycin was second (27 %), and mitomycin C was third (20%) in this class of agents.<BR>Other anticancer agents used in the field of oral surgery were methotrexsate, dacarbazine doxisorubicin hydrochloride, teceleukin, etc.<BR>In our hospitals, the appropriateness of selected anticancer agents for injections was higher than had been anticipated.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果